Cardiovascular and Hypertension-Related Care
Zentiva k.s. is involved in clinical research focused on patients receiving long-term treatment with amlodipine, with attention to treatment-related peripheral oedema and its impact on tolerability in routine cardiovascular care.
- Amlodipine-associated peripheral oedema
- Antihypertensive treatment tolerability
- Lower-limb oedema assessment
The research activity is centred on evaluating clinical symptoms in both legs using objective and patient-reported assessments in adults with moderate to severe swelling linked to ongoing calcium channel blocker therapy.
Oedema Measurement and Symptom Assessment
The sponsor’s trial landscape includes comparative assessment of peripheral oedema severity, combining clinical measurement with subjective symptom reporting to characterise swelling and discomfort more precisely.
- Objective oedema measurement
- Patient-reported symptom severity
- Tolerability evaluation
This area reflects interest in how treatment-related swelling is detected, quantified, and linked to patient experience in the setting of chronic cardiovascular therapy.
Medication Switching in Chronic Therapy
Clinical research supported by Zentiva k.s. also addresses the therapeutic implications of switching from amlodipine to levamlodipine in patients affected by oedema during long-term treatment.
- Switching between antihypertensive therapies
- Symptom relief after treatment change
- Long-term medication tolerability
The focus is on whether an alternative calcium antagonist regimen can improve swelling-related symptoms while maintaining cardiovascular treatment needs.
